Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 1
Results: 39
Costs associated with United States pharmacopeia compliant infusion clinics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 141, doi. 10.1177/10781552211048871
- By:
- Publication type:
- Article
Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better?
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 203, doi. 10.1177/10781552211045909
- By:
- Publication type:
- Article
Clinical pharmaceutical screening in critical situations in a radioiodine therapy management service.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 135, doi. 10.1177/10781552211045361
- By:
- Publication type:
- Article
Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 199, doi. 10.1177/10781552211045006
- By:
- Publication type:
- Article
A contemporary review of rearranged during transfection-selective inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 175, doi. 10.1177/10781552211040542
- By:
- Publication type:
- Article
Management of chimeric antigen receptor T-cell induced cytokine release syndrome: Current and emerging approaches.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 159, doi. 10.1177/10781552211039238
- By:
- Publication type:
- Article
Cost-effectiveness of maintenance therapy after first-line treatment in metastatic colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 194, doi. 10.1177/10781552211038929
- By:
- Publication type:
- Article
Providing medication alternatives during intranasal desmopressin recall.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 190, doi. 10.1177/10781552211037860
- By:
- Publication type:
- Article
The formulary process for biosimilar additions at a comprehensive cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 185, doi. 10.1177/10781552211036710
- By:
- Publication type:
- Article
Phosphatidylinositol 3-kinase signaling inhibitors for treatment of multiple myeloma: From small molecules to microRNAs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 149, doi. 10.1177/10781552211035369
- By:
- Publication type:
- Article
Corrigendum to Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.
- Published in:
- 2022
- Publication type:
- Correction Notice
Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 232, doi. 10.1177/10781552211026375
- By:
- Publication type:
- Article
Complex regional pain syndrome in a patient with neuroendocrine tumour under treatment with everolimus.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 228, doi. 10.1177/10781552211021485
- By:
- Publication type:
- Article
Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 222, doi. 10.1177/10781552211020821
- By:
- Publication type:
- Article
Corrigendum to Lonsurf (trifluridine/tipiracil): assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer.
- Published in:
- 2022
- Publication type:
- Correction Notice
A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 242, doi. 10.1177/10781552211027931
- By:
- Publication type:
- Article
Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 237, doi. 10.1177/10781552211027348
- By:
- Publication type:
- Article
Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 255, doi. 10.1177/10781552211028636
- By:
- Publication type:
- Article
Capecitabine induced Steven–Johnson syndrome: A rare case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 250, doi. 10.1177/10781552211027945
- By:
- Publication type:
- Article
A case of palmar hypopigmentation induced by capecitabine in a gastrointestinal cancer patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 247, doi. 10.1177/10781552211027936
- By:
- Publication type:
- Article
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 215, doi. 10.1177/10781552211020802
- By:
- Publication type:
- Article
Re-use of erlotinib in a patient using osimertinib after erlotinib, case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 211, doi. 10.1177/10781552211019108
- By:
- Publication type:
- Article
Bendamustine-induced nephrogenic diabetes insipidus – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 205, doi. 10.1177/10781552211013878
- By:
- Publication type:
- Article
Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 127, doi. 10.1177/1078155220987291
- By:
- Publication type:
- Article
Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 119, doi. 10.1177/1078155220985919
- By:
- Publication type:
- Article
Exploring practice site contributions and professionalization impact of engaging student pharmacists on hematology-oncology advanced pharmacy practice experience rotations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 109, doi. 10.1177/1078155220985579
- By:
- Publication type:
- Article
Vancomycin pharmacokinetic parameters in patients undergoing hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 101, doi. 10.1177/1078155220985317
- By:
- Publication type:
- Article
Comparative study of oral and IV dexamethasone premedication in the prevention of docetaxel induced allergic reactions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 96, doi. 10.1177/1078155220984369
- By:
- Publication type:
- Article
Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 87, doi. 10.1177/1078155220984252
- By:
- Publication type:
- Article
Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 82, doi. 10.1177/1078155220984244
- By:
- Publication type:
- Article
Analysis of first-line treatment in older patients with metastasic colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 74, doi. 10.1177/1078155220984229
- By:
- Publication type:
- Article
Knowledge assessment and barriers to cancer screening among Ghanaian community pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 64, doi. 10.1177/1078155220983413
- By:
- Publication type:
- Article
Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 55, doi. 10.1177/1078155220983407
- By:
- Publication type:
- Article
Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 49, doi. 10.1177/1078155220982648
- By:
- Publication type:
- Article
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 39, doi. 10.1177/1078155220981150
- By:
- Publication type:
- Article
Pharmacokinetics of mycophenolic acid after haplo-hematopoietic stem cell transplantation in Japanese recipients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 31, doi. 10.1177/1078155220980815
- By:
- Publication type:
- Article
Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 24, doi. 10.1177/1078155220980807
- By:
- Publication type:
- Article
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 17, doi. 10.1177/1078155220980517
- By:
- Publication type:
- Article
A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®).
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 5, doi. 10.1177/1078155220974085
- By:
- Publication type:
- Article